AKTX
Akari Therapeutics
AKTX
AKTX
15 hedge funds and large institutions have $14.5M invested in Akari Therapeutics in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Millennium Management
New York
|
+$987K |
| 2 |
HP
Hikari Power
Tokyo,
Japan
|
+$277K |
| 3 |
VMI
VHCP Management II
New York
|
+$262K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$57K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$32K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$1.53M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$1.05M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$516K |
| 4 |
QF
QVT Financial
New York
|
-$310K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$94.2K |
